Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo
Demographics (2)
- AGE_ENROLLMENT - Participant age at study enrollment (phv00481771.v1.p1)
- SEX - Biological sex (phv00481762.v1.p1)
Race and Ethnicity (2)
- ETHNICITY - Ethnicity of participant (phv00481768.v1.p1)
- RACE - Self-reported race (phv00481767.v1.p1)
Substance Use (2)
- SMOKING_PACK_YEARS - Smoking history in pack years (phv00481770.v1.p1)
- SMOKING_STATUS - Smoking status of participant (phv00481769.v1.p1)
Other (14)
- AFFECTION_STATUS - Case control status of the subject for non-small cell lung cancer (phv00481766.v1.p1)
- ANALYTE_TYPE - Analyte Type of Sample (phv00481776.v1.p1)
- BODY_SITE - Body Site Where Sample was Collected (phv00481779.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00481761.v1.p1)
- EGFR_MUTATION - Somatic mutation in EGFR (Entrez GeneID: 1956) (phv00481773.v1.p1)
- IS_TUMOR - Tumor Status of Sample (phv00481777.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00481775.v1.p1)
- SAMPLE_ID - Sample ID (phv00481764.v1.p1)
- SUBJECT_ID - Subject ID (phv00481765.v1.p1)
- SUBJECT_ID - Subject ID (phv00481760.v1.p1)
- SUBJECT_ID - Subject ID (phv00481763.v1.p1)
- TKI_TREATMENT - EGFR tyrosine kinase inhibitor therapy received by participant (phv00481774.v1.p1)
- TUMOR_COLLECTION_TIMEPOINT - Treatment Timepoint at which Sample was Collected (phv00481778.v1.p1)
- TUMOR_HISTOLOGY - Histology of tumor (phv00481772.v1.p1)